Dupixent 300 MG/2 ML pen 2ML
Ended Awarded Last action
- Contract number
- SPE2DR26FL069
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $67,206
Award facts
- Contract value 100% obligated
- $67,206.18 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $67,206.18 delivery order to AmerisourceBergen Drug Corp on January 28, 2026, for the supply of Dupixent 300 mg/2 mL pen injectors. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999.99 million through December 2026. The product will be performed and delivered from the contractor's facility in Conshohocken, Pennsylvania, with an ultimate completion date of January 29, 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and subsidiary of Cencora, Inc., which serves as the parent organization.
This delivery order supports the Defense Health Agency and broader military healthcare systems by supplying a biologic medication commonly used for the treatment of atopic dermatitis and other inflammatory conditions. The award reflects the Defense Logistics Agency's strategy of leveraging established pharmaceutical prime vendor contracts to meet critical medical supply needs across the Department of Defense. No set-aside designation was applied to this award, indicating the contract was competitively evaluated on a full and open basis, consistent with AmerisourceBergen's demonstrated capability to meet federal procurement requirements for specialized pharmaceutical products across multiple therapeutic domains.
Quick answers
Who was awarded contract SPE2DR26FL069?
SPE2DR26FL069 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 28, 2026.
How much is contract SPE2DR26FL069 worth?
The government has obligated $67,206 on SPE2DR26FL069.
Is contract SPE2DR26FL069 an order under another contract?
Yes. SPE2DR26FL069 is a delivery order under SPE2DR25D1104, an indefinite delivery contract.
Was contract SPE2DR26FL069 competed?
The extent of competition for SPE2DR26FL069 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award